These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36139999)

  • 1. ESKAPE Pathogens: Looking at Clp ATPases as Potential Drug Targets.
    Motiwala T; Mthethwa Q; Achilonu I; Khoza T
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
    Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
    mSystems; 2018; 3(3):. PubMed ID: 29719870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of medicinal plants against ESKAPE: An update.
    Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS
    Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.
    Patil A; Banerji R; Kanojiya P; Saroj SD
    Pathog Glob Health; 2021 Sep; 115(6):339-356. PubMed ID: 33851566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroamphiphilic polymers exterminate multidrug-resistant Gram-negative ESKAPE pathogens while attenuating drug resistance.
    Zhou Q; Li K; Wang K; Hong W; Chen J; Chai J; Yu L; Si Z; Li P
    Sci Adv; 2024 Aug; 10(35):eadp6604. PubMed ID: 39196947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of ESKAPE virulence with a cationic heme-mimetic gallium porphyrin photosensitizer: The Trojan horse strategy that could help address antimicrobial resistance.
    Szymczak K; Woźniak-Pawlikowska A; Burzyńska N; Król M; Zhang L; Nakonieczna J; Grinholc M
    J Photochem Photobiol B; 2024 Jul; 256():112928. PubMed ID: 38723545
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Leistikow KR; May DS; Suh WS; Vargas Asensio G; Schaenzer AJ; Currie CR; Hristova KR
    mSystems; 2024 Aug; 9(8):e0071224. PubMed ID: 38990088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.
    Yu H; Xu Y; Imani S; Zhao Z; Ullah S; Wang Q
    ACS Infect Dis; 2024 Jul; 10(7):2336-2355. PubMed ID: 38866389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
    Behroozian S; Svensson SL; Davies J
    mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units.
    Teng J; Imani S; Zhou A; Zhao Y; Du L; Deng S; Li J; Wang Q
    Biomed Pharmacother; 2023 Nov; 167():115564. PubMed ID: 37748408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
    Dehbanipour R; Ghalavand Z
    J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens.
    Ragupathi NKD; Muthuirulandi Sethuvel DP; Gopikrishnan M; Dwarakanathan HT; Murugan D; Biswas I; Bakthavachalam YD; Murugesan M; George Priya Doss C; Monk PN; Karunakaran E; Veeraraghavan B
    Microb Pathog; 2023 May; 178():106064. PubMed ID: 36898591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
    Mouanga-Ndzime Y; Onanga R; Longo-Pendy NM; Bignoumba M; Bisseye C
    Antimicrob Resist Infect Control; 2023 May; 12(1):47. PubMed ID: 37173760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
    Saha U; Gondi R; Patil A; Saroj SD
    Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial Antibiotic Resistance: The Most Critical Pathogens.
    Mancuso G; Midiri A; Gerace E; Biondo C
    Pathogens; 2021 Oct; 10(10):. PubMed ID: 34684258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.